Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ergogenic Effects of Sportlegs

NCT06371521 is registered in ClinicalTrials.gov with Christopher Bell as lead sponsor.

NCT NCT06371521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06371521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ergogenic Effects of Sportlegs
Lead sponsor
Christopher Bell
Phase
Phase 1
Overall status
Completed
Start date
January 24, 2024
Completion date
June 1, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

performance enhancing product use